Smithfield Foods could be one of the year's biggest U.S. initial public offerings, with the pork producer planning to raise ...

"The Trump administration has made very clear they support growing LNG exports," Venture CEO Mike Sable told CNBC in an ...

The funds will support the development of Ascentage’s pipeline, including its lead candidate olverembatinib to treat blood ...

IPO began trading Friday on the NASDAQ. Shares opened at $17.25 per ADS, in line with the initial public offering (IPO) price of $17.25. The pharmaceutical company, already listed on the Main Board of ...

Pete Giacchi, Citadel Securities, joins 'Money Movers' to discuss Venture Global's initial public offering, the biggest IPO ...

Even as FIIs consider valuations in the secondary market high, they remain upbeat on India's market narrative, compelling them to seize every opportunity, say experts.

Harmony Biosciences Holdings, Inc.'s strong revenue growth, diverse pipeline, and undervalued stock make it a compelling buy.

As Trump's unveiling of Stargate AI boosts names like Nvidia, Palantir and Broadcom, this stock screener highlights 26 ...

Citigroup (C) and Evercore ISI are acting as book-running managers for the proposed IPO and as representatives of the underwriters. RBC Capital Markets and William Blair are acting as joint ...

Ascentage Pharma Group (AAPG) (AAPGV) (OTCPK:ASPHF), which is backed by Takeda (NYSE:TAK), has priced a $126M U.S. initial public offering. The China-based drug developer priced 7.33M shares at $17.25 ...

After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...